We would love to hear your thoughts about our site and services, please take our survey here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksBrown Group Regulatory News (BWNG)

Share Price Information for Brown Group (BWNG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 14.65
Bid: 14.00
Ask: 15.95
Change: -0.125 (-0.83%)
Spread: 1.95 (13.929%)
Open: 14.65
High: 14.65
Low: 14.65
Prev. Close: 15.10
BWNG Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Restatements of Debtor Impairment Provisions

29 Feb 2016 07:00

RNS Number : 3884Q
Brown (N.) Group PLC
29 February 2016
 

29 February 2016

 

N Brown Group plc ("N Brown" or the "Group")

RESTATEMENTS OF DEBTOR IMPAIRMENT PROVISIONS

 AND INCREASES TO REPORTED PROFITS

 

 

Following a review of the Group's accounting policies, specifically the application of International Accounting Standard 39 ("IAS 39") in relation to the provisioning for bad and doubtful receivables, N Brown announces restatements of its debtor impairment provisions and consequent increases to reported profits. This is as a direct result of a change in the technical interpretation of this accounting standard and in no way affects the way in which we have operated or will operate our business.

 

No impact on business operations

These restatements do not create any negative impact on historic cash flows or cash balances, nor do we expect any effect on banking arrangements, previous dividends or bonus payments. They do not reflect any changes to the Group's underlying trading performance or on the risk profile of the Group's debtor balances. The Group's current business practices, approach to payment arrangements and customer rehabilitation are all unaffected by the revised IAS 39 accounting treatment.

Restatements

The final audit of the Group's financial statements for the year ended 27 February 2016 has not yet commenced. However, on the basis of preliminary work undertaken in conjunction with the Group's new auditors KPMG, the Board expects to make revisions to certain Balance Sheet and Profit & Loss line items pursuant to the requirements of IAS 39. As a consequence, it will be necessary, in preparing the 2016 financial statements, to record the following, presently unaudited, adjustments to historic and current financial years:

· An adjustment to reduce net assets at 1 March 2014 by between £45million and £55million. This reflects the impact on net assets from an increase in the provision against debtors within payment arrangements, net of anticipated associated tax impacts. A similar, albeit lower, net asset adjustment will be required as at 28 February 2015.

· These net asset adjustments reflect an increase in the debtor impairment provision level from c.8.0% (expressed as a percentage of the gross debtor value) to a range of between 17.5% and 19.0% as at 1 March 2014; from c.6.5% to a range of between 15.5% and 16.5% as at 28 February 2015; and an estimated increase in the debtor impairment provision to a range of between 14.5% and 15.5% for the year ended 27 February 2016.

· Small changes, as a result of these restatements, to revenue, cost of goods sold and, therefore, percentage gross margin of Financial Services.

· The net result of the adjustments above is an increase to expected Profit before Tax for the year ended 27 February 2016 of c.£4million to £7million and of c.£3million to £4million for the previous year; and

· An increase to expected Profit after Tax for the year ended 27 February 2016 of c.£3million to £6million and of c.£2million to £3million for the previous year.

As has been previously communicated, the quality of the Group's credit book has been improving over recent years. This is the primary reason for the upward adjustments to profit for 2015 and 2016, following the higher provision to be made at 1 March 2014 as set out above. 

Restatements background

 

IAS 39 was adopted by the Group in 2005 at its introduction. Importantly, since then, Deloitte as the Group's auditors, consistently confirmed that the Group's financial statements were appropriately prepared in accordance with IAS 39. 

The revised interpretation of IAS 39 relates to the judgement over whether a credit loss has been incurred when interest or other charges are temporarily waived, even for customers who ultimately repay their full capital balance. For customers who find themselves in financial difficulties, the Group may offer revised payment terms to support the customer, encourage rehabilitation and thereby maximise long term returns. For customers under such payment arrangements where interest and/or other charges are waived, the Group's financial statements will, going forward, reflect an impairment provision for the foregone interest income upfront and the Group will continue to recognise interest or other income over time on the impaired balances. Previously, in focusing primarily on the underlying cash flow risk to the business, and in arriving at provisions against such balances, the Group was focused upon the capital element of receivables and did not consider loss of interest as an impairment loss. Debtors under payment arrangements totalled £130.8m as at 28 February 2015.

Full year results 2016

Further to the trading statement issued on 21 January 2016, the Board remains comfortable with market expectations for the current year, before accounting for the increase in profit expected as a consequence of the adjustments set out above. The Group will announce its full year results on 20 April 2016.

 

For further information:

N Brown Group

 

Angela Spindler, CEO

Craig Lovelace, CFO

Theresa Casey, Company Secretary

Bethany Hocking, Director of Investor Relations

0161 238 2202

 

 

MHP

 

 

John Olsen / Simon Hockridge

0203 128 8789

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
MSCLFFFLFTITFIR
Date   Source Headline
18th Jan 20247:00 amRNSTrading Statement
16th Oct 202311:03 amRNSDirector/PDMR Shareholding
12th Oct 20237:00 amRNSInterim Results
7th Sep 202312:13 pmRNSN Brown announces partnership with Sainsbury’s
16th Aug 20231:59 pmRNSHolding(s) in Company
15th Aug 20232:02 pmRNSHolding(s) in Company
7th Aug 20233:30 pmRNSGrant of Nil Cost Options
2nd Aug 20237:00 amRNSIssue of equity and total voting rights
26th Jul 20231:09 pmRNSHolding(s) in Company
11th Jul 202311:59 amRNSHolding(s) in Company
10th Jul 20235:12 pmRNSResults of AGM and Confirmation of Board Changes
21st Jun 20234:49 pmRNSDirector/PDMR Shareholding
15th Jun 20237:00 amRNSTrading Statement
15th Jun 20237:00 amRNSAnnual Report and Accounts and Notice of AGM
13th Jun 20239:43 amRNSDirector/PDMR Shareholding
7th Jun 20237:00 amRNSConfirmation of CFO change and Board appointment
6th Jun 20237:00 amRNSFinal Results
22nd May 20237:00 amRNSNotice of Results
24th Apr 20238:32 amRNSHolding(s) in Company
5th Apr 20237:00 amRNSDirectorate Change
29th Mar 20234:35 pmRNSPrice Monitoring Extension
27th Mar 20234:35 pmRNSPrice Monitoring Extension
24th Feb 20234:35 pmRNSPrice Monitoring Extension
23rd Feb 20237:00 amRNSDominic Appleton appointed CFO Designate
8th Feb 20234:11 pmRNSHolding(s) in Company
7th Feb 20231:14 pmRNSDirectorate Change
7th Feb 202311:44 amRNSDirector/PDMR Shareholding
7th Feb 202311:41 amRNSDirector/PDMR Shareholding
3rd Feb 20235:19 pmRNSDirector/PDMR Shareholding
3rd Feb 20237:00 amRNSDirector/PDMR Shareholding
31st Jan 202312:28 pmRNSHolding(s) in Company
31st Jan 202311:06 amRNSDirector/PDMR Shareholding
30th Jan 20232:55 pmRNSHolding(s) in Company
27th Jan 20235:09 pmRNSHolding(s) in Company
27th Jan 20237:00 amRNSDirectorate Change
23rd Jan 20233:10 pmRNSHolding(s) in Company
23rd Jan 20233:06 pmRNSDirector/PDMR Shareholding
20th Jan 20235:37 pmRNSDirector/PDMR Shareholding
19th Jan 20234:42 pmRNSHolding(s) in Company
19th Jan 20234:38 pmRNSDirector/PDMR Shareholding
18th Jan 20234:01 pmRNSDirector/PDMR Shareholding
18th Jan 20233:57 pmRNSDirector/PDMR Shareholding
17th Jan 20238:14 amRNSDirector/PDMR Shareholding
16th Jan 20233:30 pmRNSDirector/PDMR Shareholding
16th Jan 20237:00 amRNSHolding(s) in Company
12th Jan 20234:35 pmRNSPrice Monitoring Extension
12th Jan 20237:00 amRNSTrading Statement
9th Jan 20237:00 amRNSSettlement of a Legal Dispute
28th Dec 20224:40 pmRNSSecond Price Monitoring Extn
28th Dec 20224:35 pmRNSPrice Monitoring Extension

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.